Functional analysis of a gene showing a synthetic lethal phenotype for BAP1 mutation in malignant mesothelioma

被引:0
|
作者
Kobayashi, Kirara [1 ,2 ]
Suzuki, Koya [2 ]
Miida, Takashi [2 ]
Sekido, Yoshitaka [2 ]
Murakami, Yuko [1 ,2 ]
机构
[1] Tokyo Univ Tech, Grad Sch Bion, Mol Canc Genet Lab, Tokyo, Japan
[2] Juntendo Univ, Grad Sch Med, Dept Clin Lab Med, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P4-1-1
引用
收藏
页码:947 / 947
页数:1
相关论文
共 50 条
  • [21] Somatic BAP1 and NF2 mutations in pleural malignant mesothelioma and their correlation with clinical phenotype
    Gennatas, S.
    Lu, S. K.
    Anbunathan, H.
    Popat, S.
    O'Brien, M.
    Lim, E.
    Fernandez, A. Montero
    Benepal, T.
    Nicholson, A. G.
    Lathrop, M.
    Moffatt, M.
    Cookson, W.
    Bowcock, A. M.
    LUNG CANCER, 2017, 103 : S25 - S26
  • [22] Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?
    Pulford, Emily
    Huilgol, Kalyani
    Moffat, David
    Henderson, Douglas W.
    Klebe, Sonja
    DISEASE MARKERS, 2017, 2017
  • [23] Prevalence of germline BAP1 mutations in patients with malignant mesothelioma (MM)
    Hellmann, Matthew David
    Borsu, Laetitia
    Zehir, Ahmet
    Cheng, Donavan T.
    Zha, Zheng
    Siegel, Beth
    Rohrer, Rebecca W.
    Robson, Mark E.
    Arnold, Angela G.
    Fleischut, Megan Harian
    Cavatore, Magali
    Gaskeil, Alice A.
    Gawel, Craig
    Robertson, Alexander
    Viale, Agnes
    Rusch, Valerie W.
    Krug, Lee M.
    Ladanyi, Marc
    Zauderer, Marjorie Glass
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [24] High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma
    Nasu, Masaki
    Pastorino, Sandra
    Luk, Hugh
    Flores, Erin
    Baumann, Francine
    Powers, Amy
    Kanodia, Shreya
    Gaudino, Giovanni
    Zhang, Yu-an
    Gazdar, Adi
    Yang, Haining
    Pass, Harvey I.
    Emi, Mitsuru
    Carbone, Michele
    CANCER RESEARCH, 2015, 75
  • [25] BAP1 loss in malignant mesothelioma: distribution according the histological subtype
    Martin Lopez, J.
    Martin Acosta, P.
    Salas Anton, C.
    VIRCHOWS ARCHIV, 2020, 477 : S121 - S122
  • [26] Complete clinical remission of malignant peritoneal mesothelioma with systemic pemetrexed and bevacizumab in a patient with a BAP1 mutation
    Lee, Jimmy
    Turetsky, Jordan
    Nasri, Elham
    Rogers, Sherise C.
    BMJ CASE REPORTS, 2023, 16 (12)
  • [27] Determining the prevalence of germline BAP1 mutations in malignant mesothelioma (MM).
    Zauderer, Marjorie Glass
    DuBoff, Mariel A.
    Siegel, Beth
    Robson, Mark E.
    Arnold, Angela G.
    Berliner, Janice
    Fleischut, Megan Harlan
    Mandelker, Diana
    Ladanyi, Marc
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [28] High Incidence of Somatic BAP1 Alterations in Sporadic Malignant Mesothelioma
    Nasu, Masaki
    Emi, Mitsuru
    Pastorino, Sandra
    Tanji, Mika
    Powers, Amy
    Luk, Hugh
    Baumann, Francine
    Zhang, Yu-an
    Gazdar, Adi
    Kanodia, Shreya
    Tiirikainen, Maarit
    Flores, Erin
    Gaudino, Giovanni
    Becich, Michael J.
    Pass, Harvey I.
    Yang, Haining
    Carbone, Michele
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (04) : 565 - 576
  • [29] Absence of germline mutations in BAP1 in sporadic cases of malignant mesothelioma
    Sneddon, Sophie
    Leon, Justine S.
    Dick, Ian M.
    Cadby, Gemma
    Olsen, Nola
    Brims, Fraser
    Allcock, Richard J. N.
    Moses, Eric K.
    Melton, Phillip E.
    de Klerk, Nicholas
    Musk, A. W.
    Robinson, Bruce W. S.
    Creaney, Jenette
    GENE, 2015, 563 (01) : 103 - 105
  • [30] Inherited predisposition to malignant mesothelioma: germline BAP1 mutations and beyond
    Pagliuca, F.
    Marino, F. Zito
    Morgillo, F.
    Della Corte, C.
    Santini, M.
    Vicidomini, G.
    Guggino, G.
    De Dominicis, G.
    Campione, S.
    Accardo, M.
    Cozzolino, I
    Franco, R.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (12) : 4236 - 4246